David Hermanson

2.4k total citations · 1 hit paper
30 papers, 1.8k citations indexed

About

David Hermanson is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, David Hermanson has authored 30 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 14 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in David Hermanson's work include CAR-T cell therapy research (16 papers), Immune Cell Function and Interaction (10 papers) and Cancer therapeutics and mechanisms (4 papers). David Hermanson is often cited by papers focused on CAR-T cell therapy research (16 papers), Immune Cell Function and Interaction (10 papers) and Cancer therapeutics and mechanisms (4 papers). David Hermanson collaborates with scholars based in United States, Ireland and United Kingdom. David Hermanson's co-authors include Dan S. Kaufman, Branden S. Moriarity, Ye Li, Laura E. Bendzick, Chengguo Xing, Zhenya Ni, David A. Knorr, Melinda K. Hexum, Laurence J.N. Cooper and Dean A. Lee and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

David Hermanson

29 papers receiving 1.8k citations

Hit Papers

Human iPSC-Derived Natural Killer Cells Engineered with C... 2018 2026 2020 2023 2018 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
    2018 748 citations Ye Li, David Hermanson et al. Cell stem cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Hermanson United States 16 1.3k 1.1k 568 160 146 30 1.8k
Gennadi V. Glinsky United States 18 593 0.5× 571 0.5× 1.3k 2.2× 86 0.5× 44 0.3× 22 1.9k
Emmanuel T. Akporiaye United States 22 634 0.5× 661 0.6× 745 1.3× 61 0.4× 20 0.1× 51 1.6k
Yi Jer Tan China 13 373 0.3× 190 0.2× 694 1.2× 198 1.2× 35 0.2× 24 1.4k
Alexey Petukhov Russia 21 514 0.4× 244 0.2× 561 1.0× 52 0.3× 46 0.3× 54 1.2k
Hans K. Erickson United States 21 1.3k 1.1× 163 0.1× 809 1.4× 207 1.3× 60 0.4× 43 2.1k
Elodie Viry Luxembourg 13 355 0.3× 535 0.5× 534 0.9× 57 0.4× 24 0.2× 15 1.3k
Masaki Nogawa Japan 19 467 0.4× 108 0.1× 598 1.1× 111 0.7× 70 0.5× 34 1.2k
Gaichao Zhao China 8 652 0.5× 177 0.2× 951 1.7× 61 0.4× 19 0.1× 13 1.5k
Hengrui Zhu United States 14 458 0.4× 262 0.2× 895 1.6× 54 0.3× 103 0.7× 22 1.2k
Mala Shanmugam United States 18 389 0.3× 163 0.1× 971 1.7× 38 0.2× 194 1.3× 42 1.4k

Countries citing papers authored by David Hermanson

Since Specialization
Citations

This map shows the geographic impact of David Hermanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hermanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hermanson more than expected).

Fields of papers citing papers by David Hermanson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hermanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hermanson. The network helps show where David Hermanson may publish in the future.

Co-authorship network of co-authors of David Hermanson

This figure shows the co-authorship network connecting the top 25 collaborators of David Hermanson. A scholar is included among the top collaborators of David Hermanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hermanson. David Hermanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Atala, Anthony, John C. Bischof, Christopher S. Chen, et al.. (2025). The need for an organoid manufacturing, preservation, and distribution center. Stem Cells Translational Medicine. 14(7). 1 indexed citations
2.
Gurney, Mark E., Sarah Corcoran, Sarah Brophy, et al.. (2022). Concurrent transposon engineering and CRISPR/Cas9 genome editing of primary CLL-1 chimeric antigen receptor–natural killer cells. Cytotherapy. 24(11). 1087–1094. 22 indexed citations
3.
Hermanson, David, et al.. (2022). Accelerating cell therapy discovery & development with non-viral gene engineering. Cell and Gene Therapy Insights. 8(8). 1023–1032. 1 indexed citations
4.
Gurney, Mark E., Sarah Corcoran, Janusz Krawczyk, et al.. (2021). Tc Buster Transposon Engineered CLL-1 CAR-NK Cells Efficiently Target Acute Myeloid Leukemia. Blood. 138(Supplement 1). 1725–1725. 9 indexed citations
5.
6.
Li, Ye, David Hermanson, Branden S. Moriarity, & Dan S. Kaufman. (2018). Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity. Cell stem cell. 23(2). 181–192.e5. 748 indexed citations breakdown →
7.
Smith, Jenessa B., et al.. (2018). Abstract A071: PSMA-specific CARTyrin T-stem cell memory therapy eliminates solid tumor in subcutaneous prostate cancer model. Cancer Research. 78(16_Supplement). A071–A071. 3 indexed citations
8.
Wang, Xinxin, Burton E. Barnett, Christopher E. Martin, et al.. (2017). Production of Universal Anti-Bcma CAR-T Cells with Reduced Alloreactivity, but Potent Effector Function for the Treatment of Multiple Myeloma. Blood. 130. 503–503. 3 indexed citations
9.
10.
Hermanson, David, Laura E. Bendzick, & Dan S. Kaufman. (2016). Mouse Xenograft Model for Intraperitoneal Administration of NK Cell Immunotherapy for Ovarian Cancer. Methods in molecular biology. 1441. 277–284. 8 indexed citations
11.
Barnett, Burton E., David Hermanson, Jenessa B. Smith, et al.. (2016). piggyBacTM-Produced CAR-T Cells Exhibit Stem-Cell Memory Phenotype. Blood. 128(22). 2167–2167. 17 indexed citations
12.
Hermanson, David & Dan S. Kaufman. (2015). Utilizing Chimeric Antigen Receptors to Direct Natural Killer Cell Activity. Frontiers in Immunology. 6. 195–195. 136 indexed citations
13.
14.
Johnson, Thomas E., David Hermanson, Lei Wang, et al.. (2011). Lung Tumorigenesis Suppressing Effects of a Commercial Kava Extract and Its Selected Compounds in A/J Mice. The American Journal of Chinese Medicine. 39(4). 727–742. 25 indexed citations
15.
Pappenfus, Ted M., et al.. (2010). Regiochemistry of Poly(3-hexylthiophene): Synthesis and Investigation of a Conducting Polymer. Journal of Chemical Education. 87(5). 522–525. 22 indexed citations
16.
Hermanson, David, Sadiya N. Addo, Anna Bajer, et al.. (2009). Dual Mechanisms of sHA 14-1 in Inducing Cell Death through Endoplasmic Reticulum and Mitochondria. Molecular Pharmacology. 76(3). 667–678. 43 indexed citations
17.
Shaik, Ahmad Ali, David Hermanson, & Chengguo Xing. (2009). Identification of methysticin as a potent and non-toxic NF-κB inhibitor from kava, potentially responsible for kava’s chemopreventive activity. Bioorganic & Medicinal Chemistry Letters. 19(19). 5732–5736. 26 indexed citations
18.
Doshi, Jignesh, Defeng Tian, Sadiya N. Addo, et al.. (2009). Structure−Activity Relationship and Molecular Mechanisms of Ethyl 2-Amino-4-(2-ethoxy-2-oxoethyl)-6-phenyl-4H-chromene-3-carboxylate (sHA 14-1) and Its Analogues. Journal of Medicinal Chemistry. 52(19). 5937–5949. 66 indexed citations
19.
Pappenfus, Ted M., et al.. (2007). Synthesis and Catalytic Activity of Ruthenium–Indenylidene Complexes for Olefin Metathesis. Journal of Chemical Education. 84(12). 1998–1998. 10 indexed citations
20.
Hermanson, David, et al.. (1972). An Independent Study-Seminar Program for the Gifted. Exceptional Children. 38(5). 421–426.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gennadi V. Glinsky Breakdown of academic impact, for papers by Emmanuel T. Akporiaye Breakdown of academic impact, for papers by Yi Jer Tan Breakdown of academic impact, for papers by Alexey Petukhov Breakdown of academic impact, for papers by Hans K. Erickson Breakdown of academic impact, for papers by Elodie Viry Breakdown of academic impact, for papers by Masaki Nogawa Breakdown of academic impact, for papers by Gaichao Zhao Breakdown of academic impact, for papers by Hengrui Zhu Breakdown of academic impact, for papers by Mala Shanmugam
Rankless by CCL
2026